Xanax is the brand name for alprazolam, a short-acting benzodiazepine FDA-approved for panic disorder and generalized anxiety. It produces a calming effect within 20 to 30 minutes of an oral dose. Its short half-life, rapid tolerance, severe withdrawal risk including seizures, and fatal respiratory depression when combined with opioids or alcohol are the reasons most psychiatrists prescribe it sparingly or not at all for sustained use.
What Xanax is
Xanax is the brand name for alprazolam, a medication in the benzodiazepine class. It binds to GABA-A receptors and increases the inhibitory effect of GABA, the brain's main calming neurotransmitter. It was approved by the FDA in 1981 for panic disorder and generalized anxiety. Generic alprazolam is widely available. The MedlinePlus drug information page for alprazolam covers consumer-facing essentials.
The longer reference for the benzodiazepine class is Benzodiazepines for anxiety, which sets alprazolam in context with clonazepam, lorazepam, diazepam, and the rest of the class.
What it does
Alprazolam enhances the effect of GABA at GABA-A receptors throughout the central nervous system. The effects are felt within 20 to 30 minutes of an oral dose: reduced anxiety, muscle relaxation, mild sedation, sometimes a sense of disinhibition. At higher doses, motor coordination and memory are impaired. You can watch what a benzodiazepine does at the GABA-A receptor in PsychiatryRx's interactive guide.
The mechanism is fundamentally different from SSRIs and SNRIs. Benzodiazepines act immediately and acutely; SSRIs act gradually over weeks through receptor adaptation. The trade-off is straightforward: benzodiazepines provide immediate relief and produce dependence; SSRIs don't provide immediate relief and don't produce dependence.
What it feels like
Patients describe a felt calming within 20 to 30 minutes, peaking at one to two hours. Muscle tension softens. Racing thoughts slow. Sleep onset is easier. The effect of a single dose typically lasts 4 to 6 hours.
The same short half-life that makes alprazolam useful for an acute episode also makes it especially prone to producing inter-dose withdrawal: rebound anxiety as the drug level falls, often worse than the original symptoms. This is one reason regular three-times-daily use of alprazolam often creates a pattern of escalating use over time.
When it's chosen
The clinical case for alprazolam, when it's chosen, is usually one of:
- Short-term use during a discrete crisis (one to two weeks of bridging while an SSRI takes effect)
- Procedural anxiety for a specific event (MRI, dental procedure, flight)
- Patients with severe panic disorder who haven't tolerated longer-acting benzodiazepines and require a faster-acting option
It's rarely the right choice for sustained treatment of generalized anxiety or panic disorder. The American Psychiatric Association practice guidelines and the NIMH anxiety disorders overview both recommend SSRIs, SNRIs, or CBT as first-line, with benzodiazepines reserved for specific short-term use.
Typical dosing and timeline
Starting dose for panic disorder is typically 0.25 to 0.5 mg two or three times daily. Doses can be titrated, but the dependence and tolerance risk rises quickly with daily use beyond two to four weeks. Extended-release alprazolam (Xanax XR) was developed partly to smooth the inter-dose withdrawal, but the dependence risk remains.
For short-term bridging while an SSRI takes effect, two to four weeks of intermittent use is a typical pattern. Beyond that, the risk-benefit balance shifts unfavorably.
Side effects and cautions
Sedation, impaired motor coordination, and memory impairment are dose-related. Cognitive effects are particularly concerning in older adults; benzodiazepines are listed on the American Geriatrics Society Beers Criteria as medications to avoid except in narrow situations.
The FDA boxed warning addresses three specific risks:
- Concomitant use with opioids increases the risk of fatal respiratory depression. This combination has been a major contributor to overdose deaths.
- Abuse, misuse, and addiction develop in a meaningful fraction of patients on regular use.
- Physical dependence develops within weeks. Abrupt discontinuation can produce severe withdrawal including seizures, which can be fatal.
Alcohol potentiates all of the above and dramatically increases the respiratory depression risk.
What Xanax doesn't do
Xanax doesn't treat the underlying anxiety disorder. The acute effect is symptomatic relief, not durable change. When the dose wears off, the underlying condition is unchanged.
Xanax doesn't work indefinitely. Tolerance to the anxiolytic effect develops within weeks to months for many patients. Dose escalation that follows is a common path into dependence.
Xanax isn't a substitute for sustained treatment. For ongoing panic disorder or generalized anxiety, the durable approaches are SSRIs or SNRIs combined with CBT and, for panic disorder, interoceptive exposure.
Comparison with related medications
Compared with clonazepam, alprazolam has a faster onset and shorter duration, which makes it more useful for an acute episode and more prone to inter-dose withdrawal. Compared with lorazepam, alprazolam has more rapid tolerance and a steeper dependence trajectory. The full class comparison is in Benzodiazepines for anxiety, and the broader trade-off against first-line treatment is in Benzodiazepine vs SSRI for panic.